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Cancer drug Imatinib, a 2-phenylaminopyrimidine derivative by chemical nature,
is a selective Abl tyrosine kinase inhibitor that does not inhibit the closely related
tyrosine kinase c-Src. To explain this observation, it was suggested that Abl can
adopt an inactive conformation that binds Imatinib without paying a high energy
penalty, whereas c-Src can’t. From this, it can be extrapolated that a design of
an inhibitor that binds to the inactive conformation of c-Src with high affinity
would not be feasible. Dar et al. now report the exciting discovery of a series
of such inhibitors that are capable of inducing the generally unfavorable confor-
mation in c-Src. (Figure credits: Dar et al.)
ABC of Haloduracin Rings
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Hala and Halb are the two peptide components of a lantibiotic, haloduracin,
formed from two posttranslationally modified precursor peptides that act syner-
gistically to kill bacteria. Cooper et al. now investigate the role of the individual
thioether rings that form unique haloduracin structure using an in vitro biosyn-
thetic system. Their systematic study reveals interesting complexity of the differ-
ent ring roles, demonstrating that both Hala and Halb rings have varying degrees of essentiality for synergistic activity. Additionally,
the study suggests that one or more secreted proteases are responsible for proteolytic processing of haloduracin, thus providing
valuable insight into this process.
Secrets of the Alnumycin Gene Cluster
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Alnumycin is an aromatic polyketide antibiotic closely related to benzoisochromanequinone (BIQ) compounds like actinorhodin. The
complete alnumycin (aln) gene cluster fromStreptomyces sp. CM020 was cloned, sequenced, and expressed in a heterologous host,
and the results are reported here by Oja et al. Inactivation of the genes aln4 and aln5 and chemical characterization of the mutant
strains revealed the involvement of these genes in pyran ring formation and suggests that Aln4 functions as a C-15 ketoreductase.
Deletion of the genes alnA and alnB resulted in the production of a novel polyketide, prealnumycin, indicating that these genes are
involved in synthesis and attachment of an unusual dioxan moiety.
Evolution of Carbohydrate Metabolism in Human Gut Flora
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Glycosidic bond cleavage, catalysed by glyco-
side hydrolases, yields one of two stereo-
chemical outcomes where configuration of
the reactive center is either retained or in-
verted. The difference in mechanism reflects
the dispositions of the functional groups within
the active site of the enzyme, which is con-
served within 112 sequence-based families.
Gloster et al. demonstrate that family 97 en-
zymes have diverged from this general princi-
ple as the family contains both inverting and
retaining enzymes. Evolutionary pressures
may have encouraged these subtle differences
between closely related enzymes, enabling them to acquire two different reaction mechanisms and thus generate stereo-
chemically distinct products. (Figure adapted from Gloster et al.)
NAD Utilizing Enzyme Juggling Act
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Enzymatic utilization of NAD requires the cleavage of the nicotinamide moiety from the substrate and the formation of a reactive in-
termediate. Liu et al. show that human CD38, an NAD utilizing enzyme, is capable of catalyzing such cleavage reactions through both
covalent and noncovalent intermediates. The covalent intermediate results in mechanism-based enzyme inactivation, while the non-
covalent intermediate appears to remain reactive. The structural results favor the proposal of a noncovalent intermediate during NAD
catalysis by human CD38 and provide insights into the design of covalent and noncovalent inhibitors targeting NAD utilization path-
ways.
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Enzymes in the chalcone synthase superfamily of type III polyketide synthases (PKSs) produce a wide variety of small molecules that
have a range of biological function. Neurospora crassa 20-oxoalkylresorcylic acid synthase (ORAS), a fungal type III PKS, produces
pyrones, resorcinols, and resorcylic acid products. The structures of ORAS, reported by Rubin-Pitel et al., reveal an active site that
is distinct from those of previously studied type III PKS and a gating mechanism that controls the production of polyketides. The func-
tion of individual amino acids in this altered active site has been furtherclarified using site-directed mutagenesis. With the structural and
functional information available, future engineering experiments on ORAS aimed at generating novel metabolites can now be designed.
s Factors and More s Factors
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s factors are prokaryotic transcription initiation fac-
tors that bind to RNA polymerase and guide its
binding to specific promoter regions. While there
is a wealth of structural data on s factors, to date
there has been no structure available of s1.1, until
now (see Schwartz et al.) In addition to describing
s1.1 structural features, the authors have synthe-
sized and applied a new chemical crosslinker,
which will also be useful for studying transient inter-
actions in other systems. Finally, the authors have
addressed a long-standing mechanistic issue in pro-
karyotic transcription; namely, how s factors are
autoinhibited by demonstrating that s1.1 interacts
with the s factor DNA binding domains, suggesting
a compacted structure that is incompatible with
DNA binding. (Figure adapted from Schwartz et al.)
One FIAsH and Two Cys-Xxx-Cys
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Successful engineering of genetically encoded, two-part dye-binding sequences across strands of a b sheet in a model protein is
now reported by Krishnan and Gierasch. The two Cys-Xxx-Cys components of the binding sequence together make up a tetra-
Cys motif, which binds the fluorophore FlAsH; thus, the cross-strand split tetra-Cys motifs would bind the reporter fluorophore in
a structure-dependent manner. Although one motif bound FlAsH only in native form, two others retained dye binding when dena-
tured, indicating that some structures in the unfolded ensemble satisfy the spatial requirements for dye interaction. Additionally,
the authors show that split tetra-Cys motifs can be used to assess cross-strand proximities in vivo.
Into the Bright Blue
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Subach et al. now report a structure-based strategy to de-
velop bright Blue Fluorescent Proteins (BFPs) by utilizing ra-
tional site-specific mutagenesis strategy and starting from
Red Fluorescent Protein. The result, mTagBFP, contains a
tyrosine residue uniquely positioned in the chromophore,
providing mTagBFP with advantages when compared to
currently available BFPs with a histidine residue in the chro-
mophore. Those advantages include higher brightness,
higher chromophore formation rate, extraordinary pH stabil-
ity, distinctive fluorescence lifetime, and narrower fluores-
cence spectrum. Finally, the authors demonstrate that
mTagBFP is a donor of choice for FRET applications with
GFP, since it exhibits very low background FRET due to its
true monomeric state and, thus, inability to dimerize with
FRET partners. (Figure adapted from Subach et al.)
Turn on the Riboswitch
PAGE 1125
The tetracycline aptamer is an artificially evolved RNA that binds the antibiotic with a subnanomolar dissociation constant and high
specificity. It is one of few aptamers that has been successfully employed as a small-molecule-responsive genetic switch in vivo. Xiao
et al. now describe a structure of the aptamer bound to the antibiotic that reveals how the RNA binds to tetracycline with an affinity
1000 times higher than that of the biological target, the ribosome. Moreover, the overall architecture of the aptamer and the local
folding transition it undergoes upon tetracycline binding are both reminiscent of natural gene-regulatory RNAs (riboswitches).
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